GROWTH & DEVELOPMENT

Babies Born Small (Small for Gestation/SGA) – do they fall short ?

June 28, 2021 Dr. Smita Ramachandran 2 min read
Babies Born Small (Small for Gestation/SGA) – do they fall short ?

Babies born Small for Gestational Age (SGA) have birth weight and/or length below the 3rd percentile for their gestational age. While approximately 90% of SGA infants achieve spontaneous “catch-up growth” within the first two years of life, the remaining 10% do not, remaining permanently short into adulthood without specialized pediatric endocrine care.

Key Clinical Takeaway: If an SGA child does not show substantial catch-up growth by age 2 to 4 years, Growth Hormone therapy is approved and highly effective to restore linear height to the normal parental range.
Q1

What Defines a Small for Gestational Age (SGA) Baby?

A newborn is clinically defined as Small for Gestational Age (SGA) when birth weight and/or crown-heel length is at least 2 standard deviations below the population mean (< -2 SD), which corresponds to below the 3rd percentile on gender-specific gestational growth charts.

Q2

What Are the Major Causes of Being Born SGA?

SGA stems from multifactorial fetal, maternal, and placental origins:

  • Fetal Factors: Chromosomal anomalies, genetic imprinting syndromes (Silver-Russell syndrome), and congenital intrauterine infections (TORCH).
  • Maternal & Placental: Placental insufficiency, pre-eclampsia, maternal hypertension, gestational diabetes, maternal malnutrition, or short maternal stature.
  • Environmental: Exposure to tobacco smoke, extreme high altitude, air pollution, and maternal prescription medications.
Q3

What Are the Short-Term and Long-Term Health Risks?

Immediate Neonatal Risks:

  • Neonatal hypoglycemia due to diminished glycogen and fat stores (affecting 1 in 3 SGA infants).
  • Impaired thermoregulation and hypothermia compared to appropriate-for-gestational-age peers.
  • Polycythemia and thrombocytopenia (>50% incidence in severe SGA).

Long-Term Adult Metabolic Concerns:

  • Persistent Short Stature: Children who fail to catch up by age 2 account for roughly 10% of all short adults.
  • Metabolic Syndrome: SGA infants experiencing rapid early weight catch-up carry higher lifetime risks of central obesity, insulin resistance, Type 2 Diabetes, and early hypertension.
Q4

Growth Monitoring & Endocrine Intervention Protocol

0–12 Mo

Quarterly Measurements

Length, weight, and head circumference plotted every 3 months on gestational growth charts.

1–2 Yrs

Catch-Up Assessment

Assess if linear growth has crossed centiles toward the mid-parental target height.

2–4 Yrs

Endocrine Referral

If height remains below -2 SD with no catch-up velocity, pediatric endocrine evaluation is required.

4+ Yrs

Growth Hormone Therapy

Recombinant GH therapy accelerates linear height and normalizes adult stature.

Close monitoring of growth velocity in children born SGA ensures that children without catch-up growth receive timely intervention before bone age advances.

Have questions about your child's health?

Consult our specialist for personalised guidance and care.

Book an Appointment